Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

4 Jan 2007 07:00

Tarsus Group PLC04 January 2007 4 January 2007 TARSUS GROUP PLC TRADING UPDATE Tarsus Group PLC ("Tarsus" or "the Group"), the international media group withinterests in exhibitions, conferences, publishing and online media has continuedto trade well in the second half of 2006. Trading for the full year remains inline with Directors' expectations notwithstanding significant US Dollar weaknessin the second half of our financial year. Like-for-like organic revenue growth was a healthy 14%, led by 2 of the Group'slargest events during the year - Labelexpo Americas and Heavent (France) - whichtraded above this overall level. The August Off-Price show once again producedrecord revenues which were slightly ahead of the 2005 result. Generally,attendances at our events in the second half were strong, particularly in Francewhich is benefiting from an improving economic environment. Revenues from emerging markets doubled on a like-for-like basis. We havecontinued to develop our Chinese portfolio throughout 2006 and expect this to bean area of further development in 2007. Caroo - our online business - trebled its revenues, boosted by the acquisitionsof Onrec and TSNN.com. Annualised revenues at Caroo are now running atapproximately £2 million. Elsewhere, Labels and Labelling magazine had anothergood year with revenues up by 10%. Our organic growth strategy has been supplemented by a small number of focusedacquisitions. In October we acquired Proseg, the leading annual facilitiesmanagement exhibition in Paris and then, in November, we announced the purchaseof 80% of Medical Conferences International Inc. (MCII). This was accompanied bya vendor placing of 5.3 million new ordinary shares at 207p, raisingapproximately £10.5 million after expenses. MCII is the leading anti-ageing andregenerative medicine conference and exhibition in the United States with annualevents in Las Vegas, Orlando and Chicago. A number of joint ventures toreplicate the event outside of the United States have been agreed for 2007. TheDecember Las Vegas event produced a strong performance with revenues andattendees up by 55% and 34% respectively, both slightly ahead of ourexpectations at the time of acquisition. Integration is proceeding well. MCII creates a fifth major division to our business and further adds to theorganic growth capability of the Group. Outlook for 2007 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. For 2007, we expect continuedgood levels of organic growth in our portfolio as a result of the increasedlevel of new product development that we have undertaken in the last two years,as well as from the recent acquisitions that we have completed. In 2007, our Labelexpo exhibition returns to Europe and, as a result, we expectour US$ denominated earnings to be nearer 50% of the Group's total earningscompared with approximately 90% in 2006. Forward booking for this - our largestsingle event - are strong. The underlying momentum of the business is positive and we continue to generatestrong cash flows which are being reinvested for further growth. Although we areat a very early stage of the year, the Directors are confident that 2007 will beanother year of strong progress for the Group. Ends For further information please contact: Tarsus Group plc: Douglas Emslie Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jan 20107:00 amRNSChange of Adviser
6th Jan 20107:00 amRNSTrading Statement
27th Nov 20092:07 pmRNSHolding(s) in Company
19th Nov 20097:00 amRNSInterim Management Statement
4th Nov 20093:38 pmRNSBlock Listing / Directors' Holdings
30th Oct 20097:00 amRNSTotal Voting Rights
14th Sep 20097:00 amRNSCorporate Update
8th Sep 20092:05 pmRNSDoc re. Scrip Dividend Circular
28th Aug 200910:39 amRNSTotal Voting Rights
25th Aug 200911:00 amRNSStatement re Interim Financial Statements 2009
29th Jul 20097:00 amRNSInterim Results
28th Jul 20095:20 pmRNSScheme of arrangement declared effective
28th Jul 20093:12 pmPRNOffer Update/Issue of equity
22nd Jul 20092:46 pmRNSOffer Update
16th Jul 20092:40 pmPRNRule 2.10 Announcement
16th Jul 200911:56 amRNSRule 8.3 - Tarsus Group Plc
10th Jul 20092:49 pmRNSRule 8.3- Tarsus Group plc
8th Jul 200911:30 amRNSRule 8.3- Tarsus Group PLC
6th Jul 20097:00 amRNSPlacing
3rd Jul 20093:05 pmRNSOffer Update
1st Jul 20097:00 amRNSTrading Statement
11th Jun 200912:20 pmRNSRule 8.3- Tarsus Group plc
11th Jun 200911:54 amRNSRule 8.3- Tarsus Group
10th Jun 20095:12 pmRNSOffer Document Posted
10th Jun 20093:41 pmRNSDirector/PDMR Shareholding
9th Jun 20096:10 pmPRNAcquisition(s)
29th May 20097:00 amRNSTotal Voting Rights
14th May 20093:29 pmRNSScrip dividend circular
11th May 20093:27 pmRNSIssue of Equity
1st May 20097:00 amRNSInterim Management Statement
30th Apr 20096:03 pmRNSResult of AGM
30th Apr 20097:00 amRNSTotal Voting Rights
30th Mar 20095:24 pmRNSAdditional Listing
3rd Mar 20097:00 amRNSFinal Results
6th Jan 200911:33 amRNSTotal Voting Rights
6th Jan 20097:00 amRNSTrading Statement and Board change
6th Jan 20097:00 amRNSTrading Update and Board Change
22nd Dec 20081:43 pmRNSDirector Shareholding
19th Dec 20087:00 amRNSDirectorate Change
15th Dec 200811:46 amRNSPDMR Shareholding
2nd Dec 20081:02 pmRNSReduction of Capital
26th Nov 20088:00 amRNSCancellation
25th Nov 20082:18 pmRNSCourt sanctions Scheme of Arrangement
24th Nov 200812:09 pmRNSNotification of Dubai presentation
21st Nov 20089:12 amRNSPDMR Shareholding
18th Nov 20084:43 pmRNSSecond Price Monitoring Extn
18th Nov 20084:38 pmRNSPrice Monitoring Extension
11th Nov 20085:12 pmRNSAdditional Listing
11th Nov 20085:08 pmRNSPDMR Shareholding
3rd Nov 20087:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.